Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis

H-L Li1, S Liang, J-H Cui

  • 1The 2nd Department of General Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, Heilongjiang, China.

Insights

This study on gastric cancer cell proliferation and apoptosis has been withdrawn due to suspected research misconduct. The authors did not provide evidence of data originality.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Gastric cancer is a significant global health concern.
  • MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
  • Glycogen synthase kinase 3 beta (GSK-3β) is implicated in various cellular processes, including proliferation and apoptosis.

Purpose of the Study:

  • To investigate the role of miR-214 in targeting GSK-3β.
  • To understand the impact of this targeting on gastric cancer cell proliferation.
  • To examine the effect on gastric cancer cell apoptosis.

Main Methods:

  • In vitro studies involving gastric cancer cell lines.
  • Analysis of miR-214 expression levels.
  • Assessment of GSK-3β protein levels and activity.
  • Cell proliferation assays.
  • Cell apoptosis assays.

Main Results:

  • The article reported that miR-214 targets GSK-3β.
  • It suggested that this targeting facilitates gastric cancer cell proliferation.
  • The study indicated a decrease in cell apoptosis.

Conclusions:

  • The findings suggested a mechanism involving miR-214 and GSK-3β in gastric cancer.
  • The study aimed to provide insights into potential therapeutic targets.
  • However, the article has been withdrawn due to research misconduct concerns.

Related Concept Videos